News und Analysen

Amdocs (NASDAQ:DOX) reported fiscal second-quarter 2026 revenue and non-GAAP earnings above the midpoint of its guidance, while newly appointed Chief Executive Officer Shimie Hortig used the

• 3 Lesser-Known Healthcare Names With Major Upside in Store

Sanuwave Health (NASDAQ:SNWV) reported record first-quarter revenue and rising consumables utilization, while management said the advanced

Brenntag (ETR:BNR) said its first-quarter 2026 results reflected a slow start to the year followed by a sharp improvement in March as volatility tied to the crisis in the Middle East lifted pricing

• Why Wyndham Hotels Is The Industry Value Play, An Earnings Story

Atour Lifestyle (NASDAQ:ATAT) reported sharply higher first-quarter revenue for 2026, driven by continued expansion of its hotel

• Cabot Boosting Production In Lithium Battery Chain For EV Market

Orion (NYSE:OEC) raised its full-year earnings outlook after reporting first-quarter adjusted EBITDA that exceeded internal

Caris Life Sciences (NASDAQ:CAI) executives said the company is expanding its commercial reach, product pipeline and biopharma partnerships as it looks to build on recent revenue growth following

Envista (NYSE:NVST) reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and

Enviri (NYSE:NVRI) reported first-quarter 2026 revenue that was flat from a year earlier, while executives said the company remains on track to complete the sale of Clean Earth and the spin-off of

Babcock International Group (LON:BAB) executives said the defense contractor delivered a strong underlying performance in fiscal 2026, but the update was overshadowed by a new GBP 140 million

Grenke (ETR:GLJ) said its first-quarter 2026 results showed progress on profitability and cost discipline despite what Chief Financial Officer Dr. Martin Paal described as an “unchanged

Navigator (NYSE:NVGS) reported record quarterly net income for the first quarter of 2026, as stronger ethylene export terminal activity and gains from vessel sales helped offset slightly softer

Talanx (ETR:TLX) reported what Chief Financial Officer Jan called the strongest first-quarter result in the company’s history, with net income rising 28% year over year to EUR 774 million in the

Ingevity (NYSE:NGVT) reported higher first-quarter 2026 sales and reaffirmed its full-year outlook as management highlighted progress on portfolio simplification, strong margins in its Performance

• Analysts' Top 3 Retail Picks Gearing Up for a Strong 2025

Natural Grocers by Vitamin Cottage (NYSE:NGVC) reported modest sales growth and higher earnings for its fiscal second quarter, as